Clinical significance of the lymphocyte function in systemic lupus erythematosus
Hara, M.
Ryumachi 17(1): 6-16
1977
ISSN/ISBN: 0300-9157 PMID: 847545 Document Number: 118492
Document emailed within 1 workday
Related Documents
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222Bi, L.Q.; Song, Y.; Sun, R.W. 1990: Lymphocyte phenotypes and their correlation with clinical features in systemic lupus erythematosus (SLE) Zhonghua Nei Ke Za Zhi 29(12): 720
Yoshida, K.; Yukiyama, Y.; Miyamoto, T. 1987: Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus Journal of Rheumatology 14(3): 490-496
Nakano, M.; Ohuchi, Y.; Hasegawa, H.; Kuroda, T.; Ito, S.; Gejyo, F. 2000: Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus Journal of Rheumatology 27(6): 1403-1407
Pigrau, A.; Martínez-Vázquez, J.M.; Bacardí, R.; Ocanña, I.; Pahissa, A. 1984: Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus Medicina Clinica 83(19): 787-791
Novak, S. 2009: Clinical significance of antinuclear antibodies and other serological abnormalities in systemic lupus erythematosus (SLE) Reumatizam 56(2): 22-25
Ljaljević, M.; Ljaljević, J.; Kunosić, J.; Zlatković, L. 1985: The level of the T lymphocyte and B lymphocyte subpopulations in patients with systemic lupus erythematosus Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 37: 131-139
Kuryliszyn-Moskal, A.; Klimiuk, P.Adrian.; Ciolkiewicz, M.; Sierakowski, S. 2008: Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus Journal of Rheumatology 35(7): 1307-1313
Li, X.; Sun, J.; Mu, R.; Gan, Y.; Wang, G.; He, J.; Yi, L.; Wang, Q.; Sun, X.; Li, Z. 2019: The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus Clinical and Experimental Rheumatology 37(3): 474-480
Tang, F.L.; Dong, Y.; Chang, P.Z. 1990: Detection and clinical significance of anti-histone antibody in systemic lupus erythematosus and rheumatoid arthritis Zhonghua Nei Ke Za Zhi 29(4): 221-223; 253
Parker, M.D. 1973: Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease Journal of Laboratory and Clinical Medicine 82(5): 769-775
Gheita, T.A.; Abdel Rehim, D.M.; Kenawy, S.A.; Gheita, H.A. 2015: Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage Acta Reumatologica Portuguesa 40(2): 145-149
Zech, P.; Richard, P.; Blanc-Brunat, N.; Labeeuw, M.; Colon, S.; Pozet, N.; Dupont, E.; Fries, D.; Traeger, J. 1972: Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology Journal d'Urologie et de Nephrologie 78(12): 987-993
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Türk, H. 1993: Systemic diseases--the significance of early diagnosis exemplified by systemic lupus erythematosus and Wegener's granulomatosis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(12): 614-619
Miyoshi, Y.; Kilpatrick, K.A.; Kelley, R.O.; Searles, R.P.; Williams, R.C. 1985: Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus Journal of Rheumatology 12(6): 1097-1104
Becker, H.; Schauer, U.; Helmke, K. 1986: B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus Clinical and Experimental Immunology 66(2): 365-372
Fuks, A.; Carballal, G.; Manni, J.A. 1979: Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations Medicina 39(3): 289-297
Bach, J.F.; Viard, J.P. 1990: Hypothesis: systemic lupus erythematosus as a disease secondary to polyclonal lymphocyte activation Clinical and Experimental Rheumatology 8(Suppl 5): 57-64
Urdaneta Carruyo, E.; Abrego Adarme, E.; Mota Hernández, F. 1982: Significance of fever in systemic lupus erythematosus in childhood Boletin Medico del Hospital Infantil de Mexico 39(4): 269-272